CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
167 hedge funds and large institutions have $1.68B invested in Clovis Oncology, Inc. in 2016 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 48 increasing their positions, 59 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
19% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 59
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
Holders
167
Holding in Top 10
8
Calls
$69.3M
Puts
$42.5M
Top Buyers
| 1 | +$46M | |
| 2 | +$22.7M | |
| 3 | +$19.1M | |
| 4 |
Millennium Management
New York
|
+$18.3M |
| 5 |
PC
Passport Capital
San Francisco,
California
|
+$17M |
Top Sellers
| 1 | -$50.2M | |
| 2 | -$37.5M | |
| 3 | -$35.6M | |
| 4 |
Morgan Stanley
New York
|
-$26.8M |
| 5 |
IHM
Iguana Healthcare Management
New York
|
-$25.5M |